ArgBP2b inhibitors are a class of chemical compounds designed to target the ArgBP2b protein, which plays a crucial role in intracellular signaling pathways. ArgBP2b is part of the ArgBP2 family, known for their involvement in various cellular processes, including actin cytoskeleton organization, cell adhesion, and migration. The inhibition of ArgBP2b can significantly affect these biological pathways, disrupting normal cellular functions such as cytoskeletal dynamics, protein-protein interactions, and signal transduction. ArgBP2b itself contains several domains, including SH3 and WW domains, which are important for its interaction with other proteins, and inhibitors are often designed to disrupt these specific interactions. By binding to these domains or allosteric sites, ArgBP2b inhibitors can modulate the protein's activity and its interactions with key cellular components.
ArgBP2b inhibitors are typically studied for their ability to affect cellular architecture and mechanical properties. This includes influencing the remodeling of the actin cytoskeleton, which is essential for maintaining cell shape and facilitating movement. These inhibitors are also used in research focused on cellular adhesion mechanisms, where ArgBP2b plays a pivotal role by interacting with adhesion molecules at the membrane. Changes in these processes can have widespread effects on cellular behavior, particularly in dynamic environments where cells undergo migration or structural changes. Researchers investigating the molecular mechanics of cellular structure often employ ArgBP2b inhibitors to gain a deeper understanding of protein networks involved in these processes, providing insights into how intracellular signaling cascades are regulated at the molecular level.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This compound may downregulate ArgBP2b by increasing acetylation of histones, enhancing the accessibility of chromatin to repressive transcription factors specific to the ArgBP2b gene. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By reducing methylation levels at the ArgBP2b gene promoter, 5-Azacytidine could lead to a decrease in ArgBP2b mRNA transcription. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D may inhibit the synthesis of ArgBP2b mRNA by intercalating into DNA and preventing RNA polymerase from effectively transcribing the gene. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
This antibiotic could reduce the levels of ArgBP2b protein by hindering the elongation phase of mRNA translation, leading to a decrease in protein synthesis. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
By inhibiting mTOR signaling, Rapamycin might indirectly decrease the translation efficiency of ArgBP2b mRNA into functional proteins. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin may strongly inhibit RNA polymerase II, leading to a sharp decline in the transcription of the ArgBP2b gene. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
This compound could reduce ArgBP2b production by hindering the phosphorylation of RNA polymerase II, a critical step required for the initiation and elongation phases of transcription. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 may decrease the degradation of ubiquitinated transcription factors that negatively regulate ArgBP2b expression, leading to lower protein levels. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
If Sp1 is a positive regulator of ArgBP2b, Mithramycin A could downregulate expression by inhibiting Sp1's DNA binding and transcriptional activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid might decrease ArgBP2b expression by promoting the degradation of transcripts or by repressing transcription through retinoic acid receptor-mediated signaling. | ||||||